Neurocognitive Outcome and Compensating Possibilities in Children and Adolescents Treated for Acute Lymphoblastic Leukemia With Chemotherapy Only

被引:13
|
作者
Lofstad, Grete Elisabeth [1 ]
Reinfjell, Trude [1 ,2 ]
Weider, Siri [1 ]
Diseth, Trond H. [3 ,4 ]
Hestad, Knut [1 ,5 ,6 ]
机构
[1] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway
[2] St Olavs Univ Hosp, Dept Child & Adolescent Psychiat, Trondheim, Norway
[3] Oslo Univ Hosp, Div Paediat & Adolescent Med, Dept Child & Adolescent Mental Hlth Hosp, Oslo, Norway
[4] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway
[5] Innlandet Hosp Trust, Dept Res, Brumunddal, Norway
[6] Inland Norway Univ Appl Sci, Dept Hlth & Nursing Sci, Elverum, Norway
来源
FRONTIERS IN PSYCHOLOGY | 2019年 / 10卷
关键词
acute lymphoblastic leukemia; survivors; neurocognitive; long-term sequelae; compensating possibilities; SURVIVORS; IMPAIRMENT; METAANALYSIS; SEQUELAE;
D O I
10.3389/fpsyg.2019.01027
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Aim: To examine the neurocognitive outcomes in children and adolescents with acute lymphoblastic leukemia (ALL) in remission who were treated with systemic chemotherapy only (CTO). Methods: Neurocognitive performances in 36 children and adolescents, aged 8.4-15.3 years, in long-term remission from ALL 4.3-12.4 years post diagnosis, without relapse, and with no pre-diagnosis history of neurodevelopmental disorder were compared with 36 healthy controls matched for gender, age, and parents' socio-economic status. The former patients and the healthy controls completed an extensive battery of standardized neuropsychological tests. Results: Survivors who were treated by CTO obtained significantly lower scores than did healthy controls on the domains of Copy and drawing (p = 0.001; Cohen's d 0.85; after controlling for Type 1 errors q = 0.006), Arithmetic (p = 0.001; Cohen's d 0.80; after controlling for Type 1 errors, q = 0.006), and Tactile sensory functions (p = 0.008; Cohen's d 0.65; after controlling for Type 1 errors, q = 0.03). Fifty percent of the ALL group were more than 1 SD below the control groups mean on Copy and drawing. There was an interaction between age and group (ALL vs. Control, p = 0.042) on Copy and drawing, indicating that the youngest ALL patients exhibited the worst performance. The oldest ALL patients performed equal to or better than the controls. A tendency in the same direction was seen for Arithmetic and Tactile sensory functions. The ALL survivors exhibited a steeper rising learning slope on repeated tests, with lower scores on a tactile problem-solving task, tactile sensory tests, verbal memory, and visual attention, but they performed as well as the controls when stimuli were repeated. Conclusion: The results indicate that neurocognitive long-term sequelae in ALL survivors are limited to specific domains - particularly complex drawing, arithmetic, and tactile processing, and novelty processing. Cognitive deficits are shown among the youngest ALL patients. Intervention programs and school programs should account for difficulties with processing new information and taking advantage of repetitions as a strength, which may prevent survivors from falling behind their peers.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Thyroid function in children treated for acute lymphoblastic leukemia
    A. Mohn
    F. Chiarelli
    A. Di Marzio
    P. Impicciatore
    S. Marsico
    F. Angrilli
    Journal of Endocrinological Investigation, 1997, 20 : 215 - 219
  • [32] Dental abnormalities in children treated for acute lymphoblastic leukemia
    SC Kaste
    KP Hopkins
    D Jones
    D Crom
    CA Greenwald
    VM Santana
    Leukemia, 1997, 11 : 792 - 796
  • [33] Dental abnormalities in children treated for acute lymphoblastic leukemia
    Kaste, SC
    Hopkins, KP
    Jones, D
    Crom, D
    Greenwald, CA
    Santana, VM
    LEUKEMIA, 1997, 11 (06) : 792 - 796
  • [34] Attention and executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG)
    Hardy, Kristina K.
    Embry, Leanne
    Kairalla, John A.
    Sharkey, Christina
    Gioia, Anthony R.
    Griffin, Danielle
    Berger, Carly
    Weisman, Hannah S.
    Noll, Robert B.
    Winick, Naomi J.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (11)
  • [35] Surveillance and expected outcome of acute lymphoblastic leukemia in children and adolescents: An experience from Eastern India
    Mukhopadhyay, Ashis
    Gangopadhyay, Sudeshna
    Dasgupta, Swati
    Paul, Samrat
    Mukhopadhyay, Soma
    Ray, Ujjal Kanti
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2013, 34 (04) : 280 - 282
  • [36] Motor and Basic Cognitive Functions in Children with Acute Lymphoblastic Leukemia Undergoing Induction or Consolidation Chemotherapy
    Kabak, Vesile Yildiz
    Ekinci, Yasin
    Uysal, Songul Atasavun
    Cetin, Mualla
    Duger, Tulin
    PERCEPTUAL AND MOTOR SKILLS, 2021, 128 (03) : 1091 - 1106
  • [37] Chemotherapy as a risk factor for caries and gingivitis in children with acute lymphoblastic leukemia: A retrospective cohort study
    Shayani, Anis
    Aravena, Pedro Christian
    Rodriguez-Salinas, Carolina
    Escobar-Silva, Pamela
    Diocares-Monsalvez, Yandolin
    Angulo-Gutierrez, Carolina
    Rivera, Cesar
    INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, 2022, 32 (04) : 538 - 545
  • [38] Thyroid function in children treated for acute lymphoblastic leukemia
    Mohn, A
    Chiarelli, F
    DiMarzio, A
    Impicciatore, P
    Marsico, S
    Angrilli, F
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1997, 20 (04) : 215 - 219
  • [39] Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens
    Denton, Christopher C.
    Rawlins, Yasmin A.
    Oberley, Matthew J.
    Bhojwani, Deepa
    Orgel, Etan
    PEDIATRIC BLOOD & CANCER, 2018, 65 (03)
  • [40] Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia
    Nassar, Stephanie L.
    Conklin, Heather M.
    Zhou, Yinmei
    Ashford, Jason M.
    Reddick, Wilburn E.
    Glass, John O.
    Laningham, Fred H.
    Jeha, Sima
    Cheng, Cheng
    Pui, Ching-Hon
    PEDIATRIC BLOOD & CANCER, 2017, 64 (08)